Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In contrast to the enormous advances made regarding mechanisms of conventional protein secretion, mechanistic insights into the unconventional secretion of proteins are lacking. Acyl coenzyme A (CoA)-binding protein (
ACBP
; AcbA in Dictyostelium discoideum), an unconventionally secreted protein, is dependent on Golgi reassembly and stacking protein (GRASP) for its secretion. We discovered, surprisingly, that the secretion, processing, and function of an AcbA-derived peptide, SDF-2, are conserved between the yeast Pichia pastoris and D. discoideum. We show that in yeast, the secretion of SDF-2-like activity is GRASP dependent, triggered by nitrogen
starvation
, and requires autophagy proteins as well as medium-chain fatty acyl CoA generated by peroxisomes. Additionally, a phospholipase D implicated in soluble N-ethyl-maleimide sensitive fusion protein attachment protein receptor-mediated vesicle fusion at the plasma membrane is necessary, but neither peroxisome turnover nor fusion between autophagosomes and the vacuole is essential. Moreover, yeast Acb1 and several proteins required for its secretion are necessary for sporulation in P. pastoris. Our findings implicate currently unknown, evolutionarily conserved pathways in unconventional secretion.
...
PMID:Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. 2015 68
Autophagy facilitates the adaptation to nutritional stress. Here, we show that short-term
starvation
of cultured cells or mice caused the autophagy-dependent cellular release of acyl-CoA-binding protein (
ACBP
, also known as diazepam-binding inhibitor, DBI) and consequent
ACBP
-mediated feedback inhibition of autophagy. Importantly,
ACBP
levels were elevated in obese patients and reduced in anorexia nervosa. In mice, systemic injection of
ACBP
protein inhibited autophagy, induced lipogenesis, reduced glycemia, and stimulated appetite as well as weight gain. We designed three approaches to neutralize
ACBP
, namely, inducible whole-body knockout, systemic administration of neutralizing antibodies, and induction of antiACBP autoantibodies in mice.
ACBP
neutralization enhanced autophagy, stimulated fatty acid oxidation, inhibited appetite, reduced weight gain in the context of a high-fat diet or leptin deficiency, and accelerated weight loss in response to dietary changes. In conclusion, neutralization of
ACBP
might constitute a strategy for treating obesity and its co-morbidities.
...
PMID:Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. 3180 Oct 56
DBI/
ACBP
(diazepam binding protein, acyl-CoA binding protein) participates in the regulation of fatty acid metabolism when it is localized within cells, whereas outside of cells it acts as a diazepam-binding protein. Recent results indicate that many different mammalian cell types release DBI/
ACBP
upon
in vitro
or
in vivo
starvation
in a macroautophagy/autophagy-dependent fashion. The autophagy-associated release of DBI/
ACBP
elicits feedback inhibition of autophagy through 3 independent mechanisms. First, the depletion of DBI/
ACBP
from cells limits autophagy in a cell-autonomous fashion. Second, extracellular DBI/
ACBP
acts in a paracrine fashion to inhibit autophagy. Third, DBI/
ACBP
increasing in the systemic circulation acts as an activator of lipo-anabolism and feeding behavior, thus removing the cause of autophagy induction (
starvation
) and suppressing the phenomenon. DBI/
ACBP
expression is upregulated at the mRNA and protein levels in obese mice and humans, and its extracellular neutralization by antibodies controls food intake and increases lipo-catabolism. Current data support the contention that DBI/
ACBP
is an important pro-obesity factor.
Abbreviations
: DBI: diazepam binding protein, acyl-CoA binding protein; GABR: gamma-aminobutyric acid type A receptor; TSPO: translocator protein.
...
PMID:Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. 3142 3
Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after
starvation
, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor
ACBP
/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of "pseudo-diabetes".
...
PMID:Pseudodiabetes-not a contraindication for metabolic interventions. 3160 89